Amundi EURO STOXX 50 Daily (2x) Leveraged UCITS ETF Acc
Get $10 bonus on your first $100 deposit for LYMZ.DE
Get $10 bonus on your first $100 deposit for LYMZ.DE
Amundi EURO STOXX 50 Daily (2x) Leveraged UCITS ETF Acc (LYMZ.DE) Stock Competitors & Peer Comparison
See (LYMZ.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management - Leveraged Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LYMZ.DE | €73.65 | -0.59% | 210.5M | N/A | N/A | N/A |
| PJSR.DE | €106.75 | +0.16% | 1.5B | N/A | N/A | N/A |
| PJS1.DE | €97.70 | +0.15% | 1.5B | N/A | N/A | +2.97% |
| DBPG.DE | €246.25 | +0.82% | 480.4M | N/A | N/A | N/A |
| 18MS.DE | €6.86 | +0.00% | 159.1M | N/A | N/A | N/A |
| DXSN.DE | €9.69 | +1.15% | 153.6M | 30.48 | €0.32 | N/A |
| DXST.DE | €30.66 | +0.52% | 64.7M | N/A | N/A | N/A |
| DBPD.DE | €0.54 | +2.24% | 64.7M | 29.47 | €0.02 | N/A |
| DBPK.DE | €0.17 | -1.19% | 44.5M | N/A | N/A | N/A |
| DXSP.DE | €5.63 | +0.45% | 36.1M | 24.29 | €0.23 | N/A |
Stock Comparison
LYMZ.DE vs PJSR.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, PJSR.DE has a market cap of 1.5B. Regarding current trading prices, LYMZ.DE is priced at €73.65, while PJSR.DE trades at €106.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas PJSR.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to PJSR.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is more volatile compared to PJSR.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check PJSR.DE's competition here
LYMZ.DE vs PJS1.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, PJS1.DE has a market cap of 1.5B. Regarding current trading prices, LYMZ.DE is priced at €73.65, while PJS1.DE trades at €97.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas PJS1.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to PJS1.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is more volatile compared to PJS1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check PJS1.DE's competition here
LYMZ.DE vs DBPG.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, DBPG.DE has a market cap of 480.4M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while DBPG.DE trades at €246.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas DBPG.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to DBPG.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is more volatile compared to DBPG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check DBPG.DE's competition here
LYMZ.DE vs 18MS.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, 18MS.DE has a market cap of 159.1M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while 18MS.DE trades at €6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas 18MS.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to 18MS.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is more volatile compared to 18MS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check 18MS.DE's competition here
LYMZ.DE vs DXSN.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, DXSN.DE has a market cap of 153.6M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while DXSN.DE trades at €9.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas DXSN.DE's P/E ratio is 30.48. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to DXSN.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is more volatile compared to DXSN.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check DXSN.DE's competition here
LYMZ.DE vs DXST.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, DXST.DE has a market cap of 64.7M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while DXST.DE trades at €30.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas DXST.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to DXST.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is more volatile compared to DXST.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check DXST.DE's competition here
LYMZ.DE vs DBPD.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, DBPD.DE has a market cap of 64.7M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while DBPD.DE trades at €0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas DBPD.DE's P/E ratio is 29.47. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to DBPD.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is less volatile compared to DBPD.DE. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check DBPD.DE's competition here
LYMZ.DE vs DBPK.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, DBPK.DE has a market cap of 44.5M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while DBPK.DE trades at €0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas DBPK.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to DBPK.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is less volatile compared to DBPK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check DBPK.DE's competition here
LYMZ.DE vs DXSP.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, DXSP.DE has a market cap of 36.1M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while DXSP.DE trades at €5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas DXSP.DE's P/E ratio is 24.29. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to DXSP.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is more volatile compared to DXSP.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check DXSP.DE's competition here
LYMZ.DE vs DES2.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, DES2.DE has a market cap of 26.8M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while DES2.DE trades at €0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas DES2.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to DES2.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is less volatile compared to DES2.DE. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check DES2.DE's competition here
LYMZ.DE vs DX2K.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, DX2K.DE has a market cap of 19.6M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while DX2K.DE trades at €3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas DX2K.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to DX2K.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is more volatile compared to DX2K.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check DX2K.DE's competition here
LYMZ.DE vs TAB1.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, TAB1.DE has a market cap of 4.5M. Regarding current trading prices, LYMZ.DE is priced at €73.65, while TAB1.DE trades at €111.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas TAB1.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to TAB1.DE's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is more volatile compared to TAB1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check TAB1.DE's competition here
LYMZ.DE vs XBJF.DE Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, XBJF.DE has a market cap of 0. Regarding current trading prices, LYMZ.DE is priced at €73.65, while XBJF.DE trades at €42.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas XBJF.DE's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to XBJF.DE's ROE of N/A. Regarding short-term risk, LYMZ.DE is more volatile compared to XBJF.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LYMZ.DE.Check XBJF.DE's competition here
LYMZ.DE vs US9S.SG Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, US9S.SG has a market cap of 0. Regarding current trading prices, LYMZ.DE is priced at €73.65, while US9S.SG trades at €8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas US9S.SG's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to US9S.SG's ROE of N/A. Regarding short-term risk, LYMZ.DE is less volatile compared to US9S.SG. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check US9S.SG's competition here
LYMZ.DE vs VOON.SG Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, VOON.SG has a market cap of 0. Regarding current trading prices, LYMZ.DE is priced at €73.65, while VOON.SG trades at €4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas VOON.SG's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to VOON.SG's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is less volatile compared to VOON.SG. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check VOON.SG's competition here
LYMZ.DE vs IE00B7SD4R47.SG Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, IE00B7SD4R47.SG has a market cap of 0. Regarding current trading prices, LYMZ.DE is priced at €73.65, while IE00B7SD4R47.SG trades at €570.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas IE00B7SD4R47.SG's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to IE00B7SD4R47.SG's ROE of N/A. Regarding short-term risk, LYMZ.DE is less volatile compared to IE00B7SD4R47.SG. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check IE00B7SD4R47.SG's competition here
LYMZ.DE vs IE00BLS09N40.SG Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, IE00BLS09N40.SG has a market cap of 0. Regarding current trading prices, LYMZ.DE is priced at €73.65, while IE00BLS09N40.SG trades at €52.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas IE00BLS09N40.SG's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to IE00BLS09N40.SG's ROE of N/A. Regarding short-term risk, LYMZ.DE is less volatile compared to IE00BLS09N40.SG. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check IE00BLS09N40.SG's competition here
LYMZ.DE vs PCFD.SG Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, PCFD.SG has a market cap of 0. Regarding current trading prices, LYMZ.DE is priced at €73.65, while PCFD.SG trades at €605.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas PCFD.SG's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to PCFD.SG's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is less volatile compared to PCFD.SG. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check PCFD.SG's competition here
LYMZ.DE vs 0LJI.SG Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, 0LJI.SG has a market cap of 0. Regarding current trading prices, LYMZ.DE is priced at €73.65, while 0LJI.SG trades at €55.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas 0LJI.SG's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to 0LJI.SG's ROE of +0.00%. Regarding short-term risk, LYMZ.DE is less volatile compared to 0LJI.SG. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check 0LJI.SG's competition here
LYMZ.DE vs IE00B8K7KM88.SG Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, IE00B8K7KM88.SG has a market cap of 0. Regarding current trading prices, LYMZ.DE is priced at €73.65, while IE00B8K7KM88.SG trades at €8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas IE00B8K7KM88.SG's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to IE00B8K7KM88.SG's ROE of N/A. Regarding short-term risk, LYMZ.DE is less volatile compared to IE00B8K7KM88.SG. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check IE00B8K7KM88.SG's competition here
LYMZ.DE vs LU1327051279.SG Comparison April 2026
LYMZ.DE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYMZ.DE stands at 210.5M. In comparison, LU1327051279.SG has a market cap of 0. Regarding current trading prices, LYMZ.DE is priced at €73.65, while LU1327051279.SG trades at €4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYMZ.DE currently has a P/E ratio of N/A, whereas LU1327051279.SG's P/E ratio is N/A. In terms of profitability, LYMZ.DE's ROE is +0.00%, compared to LU1327051279.SG's ROE of N/A. Regarding short-term risk, LYMZ.DE is less volatile compared to LU1327051279.SG. This indicates potentially lower risk in terms of short-term price fluctuations for LYMZ.DE.Check LU1327051279.SG's competition here